{"relation": [["Pathway", "Prolinemia Type II", "Hyperornithinemia with gyrate atrophy (HOGA)", "Hyperprolinemia Type I", "Creatine deficiency, guanidinoacetate methyltransferase deficiency", "Prolidase Deficiency (PD)", "Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)", "Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]", "Hyperprolinemia Type II", "L-arginine:glycine amidinotransferase deficiency", "Arginine and Proline Metabolism", "Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)", "Ornithine Aminotransferase Deficiency (OAT Deficiency)", "Glycine and Serine Metabolism", "Sarcosinemia", "Hyperglycinemia, non-ketotic", "Non Ketotic Hyperglycinemia", "Dimethylglycine Dehydrogenase Deficiency", "3-Phosphoglycerate dehydrogenase deficiency", "Dihydropyrimidine Dehydrogenase Deficiency (DHPD)", "Dimethylglycine Dehydrogenase Deficiency"], ["Category", "Disease", "Disease", "Disease", "Disease", "Disease", "Disease", "Disease", "Disease", "Disease", "Metabolic", "Disease", "Disease", "Metabolic", "Disease", "Disease", "Disease", "Disease", "Disease", "Disease", "Disease"], ["SMPDB ID", "SMP00208", "SMP00505", "SMP00361", "SMP00504", "SMP00207", "SMP00188", "SMP00506", "SMP00360", "SMP00507", "SMP00020", "SMP00362", "SMP00363", "SMP00004", "SMP00244", "SMP00485", "SMP00223", "SMP00484", "SMP00721", "SMP00179", "SMP00242"]], "pageTitle": "DrugBank: N-[Amino(Imino)Methyl]Glycine (DB02751)", "title": "", "url": "http://www.drugbank.ca/drugs/DB02751", "hasHeader": true, "headerPosition": "FIRST_ROW", "tableType": "RELATION", "tableNum": 1, "s3Link": "common-crawl/crawl-data/CC-MAIN-2015-32/segments/1438042988048.90/warc/CC-MAIN-20150728002308-00286-ip-10-236-191-2.ec2.internal.warc.gz", "recordEndOffset": 407516159, "recordOffset": 407499672, "tableOrientation": "HORIZONTAL", "textBeforeTable": "Pathways Not Available Affected organisms Not Available Toxicity Not Available Clearance Not Available Half life Not Available Route of elimination Not Available Metabolism Not Available Protein binding Not Available Volume of distribution Not Available Absorption Not Available Mechanism of action Not Available Pharmacodynamics Not Available Indication Pharmacology N-amidino-amino acid (CHEBI:16344 ) glycine derivative (CHEBI:16344 ) External Descriptors Aliphatic acyclic compounds Molecular Framework Aliphatic acyclic compound Carbonyl group Imine Organonitrogen compound Organooxygen compound Hydrocarbon derivative Carboxylic acid Monocarboxylic acid or derivatives Carboximidamide Guanidine N-substituted-alpha-amino acid Alpha-amino acid or derivatives Substituents Carbonyl compounds Hydrocarbon derivatives", "textAfterTable": "SNP Mediated Effects Not Available SNP Mediated Adverse Drug Reactions Not Available ADMET Predicted ADMET features Property Value Probability Human Intestinal Absorption + 0.9079 Blood Brain Barrier + 0.6387 Caco-2 permeable - 0.7303 P-glycoprotein substrate Non-substrate 0.669 P-glycoprotein inhibitor I Non-inhibitor 0.9716 P-glycoprotein inhibitor II Non-inhibitor 0.9497 Renal organic cation transporter Non-inhibitor 0.8746 CYP450 2C9 substrate Non-substrate 0.8312 CYP450 2D6 substrate Non-substrate 0.7472 CYP450 3A4 substrate Non-substrate 0.8402 CYP450 1A2 substrate Non-inhibitor 0.9343 CYP450 2C9 substrate Non-inhibitor 0.9317 CYP450 2D6 substrate Non-inhibitor 0.9329 CYP450 2C19 substrate Non-inhibitor 0.9121 CYP450 3A4 substrate Non-inhibitor 0.929 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9966 Ames test Non AMES toxic 0.6378 Carcinogenicity Non-carcinogens 0.8665 Biodegradation Ready biodegradable 0.7636 Rat acute toxicity 1.5599 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9765 hERG inhibition (predictor II) Non-inhibitor 0.9734 Pharmacoeconomics Manufacturers Not Available Packagers Not Available Dosage forms Not Available Prices Not Available Patents", "hasKeyColumn": true, "keyColumnIndex": 0, "headerRowIndex": 0}